Bernhard C. Pestalozzi

Gemcitabine Plus Capecitabine Compared With Gemcitabine Alone in Advanced Pancreatic Cancer: A Randomized, Multicenter, Phase III Trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group

Richard Herrmann, G. Bodoky, Thomas Ruhstaller et al. · Journal of Clinical Oncology · 2007 · 590 citations

Distinct Clinical and Prognostic Features of Infiltrating Lobular Carcinoma of the Breast: Combined Results of 15 International Breast Cancer Study Group Clinical Trials

Bernhard C. Pestalozzi, David Zahrieh, Elizabeth Mallon et al. · Journal of Clinical Oncology · 2008 · 484 citations · Full text

Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)

Bernhard C. Pestalozzi, David Zahrieh, Karen N. Price et al. · Annals of Oncology · 2006 · 409 citations · Full text

Neuro-oncology, Breast Oncology, Cancer Risk +11

Concomitant Cisplatin Significantly Improves Locoregional Control in Advanced Head and Neck Cancers Treated With Hyperfractionated Radiotherapy

P Huguenin, Karl T. Beer, Abdelkarim S. Allal et al. · Journal of Clinical Oncology · 2004 · 252 citations · Full text

The value of PET, CT and in-line PET/CT in patients with gastrointestinal stromal tumours: long-term outcome of treatment with imatinib mesylate

Gerhard W. Goerres, Roger Stupp, Ghassan Barghouth et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2004 · 207 citations · Full text

Imatinib Mesylate, Gastrointestinal Oncology, Medicine +10